These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 34277203)

  • 21. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.
    Losen M; Stassen MH; Martínez-Martínez P; Machiels BM; Duimel H; Frederik P; Veldman H; Wokke JH; Spaans F; Vincent A; De Baets MH
    Brain; 2005 Oct; 128(Pt 10):2327-37. PubMed ID: 16150851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myasthenia Gravis and its Association With Thyroid Diseases.
    Amin S; Aung M; Gandhi FR; Pena Escobar JA; Gulraiz A; Malik BH
    Cureus; 2020 Sep; 12(9):e10248. PubMed ID: 33042687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis.
    Lindstrom JM; Einarson BL; Lennon VA; Seybold ME
    J Exp Med; 1976 Sep; 144(3):726-38. PubMed ID: 182896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and clinical classification of autoimmune myasthenia gravis.
    Berrih-Aknin S; Frenkian-Cuvelier M; Eymard B
    J Autoimmun; 2014; 48-49():143-8. PubMed ID: 24530233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immunopathology of myasthenia gravis.
    Lennon VA
    Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 Vaccination in Patients with Myasthenia Gravis: A Single-Center Case Series.
    Ruan Z; Tang Y; Li C; Sun C; Zhu Y; Li Z; Chang T
    Vaccines (Basel); 2021 Sep; 9(10):. PubMed ID: 34696220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental autoimmune myasthenia gravis in the mouse.
    Wu B; Goluszko E; Huda R; Tüzün E; Christadoss P
    Curr Protoc Immunol; 2011 Nov; Chapter 15():Unit 15.23. PubMed ID: 22048803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myasthenia gravis with autoimmune autonomic neuropathy.
    Vernino S; Cheshire WP; Lennon VA
    Auton Neurosci; 2001 May; 88(3):187-92. PubMed ID: 11474561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myasthenia gravis, respiratory function, and respiratory tract disease.
    Gilhus NE
    J Neurol; 2023 Jul; 270(7):3329-3340. PubMed ID: 37101094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-AChR, MuSK, and LRP4 antibodies coexistence: A rare and distinct subtype of myasthenia gravis from Indian subcontinent.
    Bokoliya SC; Kumar VP; Nashi S; Polavarapu K; Nalini A; Patil SA
    Clin Chim Acta; 2018 Nov; 486():34-35. PubMed ID: 30006288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myasthenia gravis.
    Pourmand R
    Dis Mon; 1997 Feb; 43(2):65-109. PubMed ID: 9118787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of anti-acetylcholine receptor antibody levels and long-term outcomes of juvenile myasthenia gravis in Taiwan: a case control study.
    Chou CC; Su IC; Chou IJ; Lin JJ; Lan SY; Wang YS; Kong SS; Chen YJ; Hsieh MY; Hung PC; Wang HS; Chou ML; Lin KL;
    BMC Neurol; 2019 Jul; 19(1):170. PubMed ID: 31319795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exacerbated muscle dysfunction by procainamide in rats with experimental myasthenia gravis.
    Yeh TM; Tami JA; Krolick KA
    Drug Chem Toxicol; 1992; 15(1):53-65. PubMed ID: 1555523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies against nicotinic acetylcholine receptor and skeletal muscle in human and experimental myasthenia gravis.
    Aarli JA; Mattsson C; Heilbronn E
    Scand J Immunol; 1975; 4(8):849-52. PubMed ID: 1215840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myasthenia Gravis and Crisis: Evaluation and Management in the Emergency Department.
    Roper J; Fleming ME; Long B; Koyfman A
    J Emerg Med; 2017 Dec; 53(6):843-853. PubMed ID: 28916122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steroids induce acetylcholine receptors on cultured human muscle: implications for myasthenia gravis.
    Kaplan I; Blakely BT; Pavlath GK; Travis M; Blau HM
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):8100-4. PubMed ID: 2236023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscle satellite cells are functionally impaired in myasthenia gravis: consequences on muscle regeneration.
    Attia M; Maurer M; Robinet M; Le Grand F; Fadel E; Le Panse R; Butler-Browne G; Berrih-Aknin S
    Acta Neuropathol; 2017 Dec; 134(6):869-888. PubMed ID: 28756524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myasthenia and the neuromuscular junction.
    Gilhus NE
    Curr Opin Neurol; 2012 Oct; 25(5):523-9. PubMed ID: 22892950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Warming yang and invigorating qi" acupuncture alters acetylcholine receptor expression in the neuromuscular junction of rats with experimental autoimmune myasthenia gravis.
    Huang HP; Pan H; Wang HF
    Neural Regen Res; 2016 Mar; 11(3):465-8. PubMed ID: 27127487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.